UPDATE 1-Concateno gets bid approaches, considers sale

(Adds detail, share price)

LONDON, July 8 (Reuters) - British drug and alcohol testing company Concateno Plc (COT.L: Quote, Profile, Research) said on Tuesday it had received a number of approaches for the company, lifting its shares by 10 percent.

Concateno said it would consider its options, including a possible sale of the company, and had appointed UBS as an advisor. Concateno didn't name the potential bidders.

The company, which listed on the junior market AIM in 2005, has become a leader in corporate testing after a series of acquisitions, including Medscreen in 2006 and Altrix and TrichoTech in 2007.

Concateno shares were up 10.2 percent at 149 pence at 0730 GMT, giving a market capitalisation of 142.4 million pounds ($280.8 million). (Reporting by Paul Sandle; Editing by Erica Billingham)